scholarly article | Q13442814 |
P50 | author | Claudiu T Supuran | Q28211545 |
Tiziano Tuccinardi | Q46649928 | ||
Mikhail Krasavin | Q55128355 | ||
P2093 | author name string | Stanislav Kalinin | |
Mikhail Korsakov | |||
Muhammet Tanç | |||
Oksana Ronzhina | |||
P2860 | cites work | Crystal structure of the secretory form of membrane-associated human carbonic anhydrase IV at 2.8-A resolution | Q24683205 |
Recent developments in targeting carbonic anhydrase IX for cancer therapeutics | Q27013023 | ||
Crystal structure of the C183S/C217S mutant of human CA VII in complex with acetazolamide | Q27663885 | ||
Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme | Q27730724 | ||
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators | Q28263238 | ||
The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C | Q28646334 | ||
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility | Q29547658 | ||
The Protein Data Bank | Q29616068 | ||
AutoDock4(Zn): an improved AutoDock force field for small-molecule docking to zinc metalloproteins | Q34089389 | ||
Tricyclic Sulfonamides Incorporating Benzothiopyrano[4,3-c]pyrazole and Pyridothiopyrano[4,3-c]pyrazole Effectively Inhibit α- and β-Carbonic Anhydrase: X-ray Crystallography and Solution Investigations on 15 Isoforms | Q58308152 | ||
Analysis of Human Carbonic Anhydrase II: Docking Reliability and Receptor-Based 3D-QSAR Study | Q58308232 | ||
Probing the 'bipolar' nature of the carbonic anhydrase active site: aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms | Q85565913 | ||
Human carbonic anhydrase inhibitory profile of mono- and bis-sulfonamides synthesized via a direct sulfochlorination of 3- and 4-(hetero)arylisoxazol-5-amine scaffolds | Q89364741 | ||
Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? | Q38011235 | ||
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling. | Q38063789 | ||
Multicomponent chemistry in the synthesis of carbonic anhydrase inhibitors | Q38991576 | ||
Structural comparison of sulfodiimine and sulfonamide inhibitors in their complexes with zinc enzymes | Q43885240 | ||
Dithiocarbamates strongly inhibit the β-class carbonic anhydrases from Mycobacterium tuberculosis | Q44803551 | ||
Secondary/tertiary benzenesulfonamides with inhibitory action against the cytosolic human carbonic anhydrase isoforms I and II. | Q45356865 | ||
Carbonic anhydrase inhibitors: inhibition of human and bovine isoenzymes by benzenesulphonamides, cyclitols and phenolic compounds. | Q45754839 | ||
Carbonic anhydrase inhibitors: in vitro inhibition of α isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids. | Q46014247 | ||
Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib | Q46806150 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P304 | page(s) | 920-934 | |
P577 | publication date | 2017-12-01 | |
P1433 | published in | Journal of Enzyme Inhibition and Medicinal Chemistry | Q15708877 |
P1476 | title | Primary mono- and bis-sulfonamides obtained via regiospecific sulfochlorination of N-arylpyrazoles: inhibition profile against a panel of human carbonic anhydrases | |
P478 | volume | 32 |
Q93008802 | Activation of human α-carbonic anhydrase isoforms I, II, IV and VII with bis-histamine schiff bases and bis-spinaceamine substituted derivatives |
Q64263067 | Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies |
Q92610527 | Synthesis and biological evaluation of novel 3-(quinolin-4-ylamino)benzenesulfonamidesAQ3 as carbonic anhydrase isoforms I and II inhibitors |
Q93010942 | Synthesis of a new series of 3-functionalised-1-phenyl-1,2,3-triazole sulfamoylbenzamides as carbonic anhydrase I, II, IV and IX inhibitors |
Search more.